
AusPAR: Saxagliptin
Related information
- Australian Public Assessment Reports for prescription medicines (AusPARs)
- Browse AusPARs by active ingredient
- Browse AusPARs by product name
- Browse AusPARs by sponsor
*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.
Australian Public Assessment Report
18 July 2012
| AusPAR | |
|---|---|
| Active Ingredient | Saxagliptin
|
| Product Name | Onglyza
|
| Sponsor | Bristol-Myers Squibb / AstraZeneca
|
| Submission Number | PM-2010-03800-3-5
|
| Submission Type | Major variation (new strength, new patient group, change in dosage)
|
| AusPAR Date | 25 June 2012
|
| Publication Date | 18 July 2012 |
